tiprankstipranks
Avanos announces two executive leadership appointments
The Fly

Avanos announces two executive leadership appointments

Avanos Medical announced two executive leadership appointments that support the company’s long-term strategic priorities: Michael Greiner has been named Chief Transformation Officer, in addition to his current responsibilities as senior vice president and chief financial officer, and Kerr Holbrook has been named senior vice president and Chief Commercial Officer. The transformation will be focused on four key priorities over the next three years: optimizing the commercial organization, transforming the product portfolio, implementing cost management initiatives to enhance operating profitability, and continuing to efficiently deploy capital while maintaining a focused and disciplined approach to M&A. Effectively immediately, Avanos will bring the North America Chronic Care and Pain franchise functions under one organization, led by Kerr Holbrook in the company’s newly created role of senior vice president and Chief Commercial Officer. Holbrook joined Avanos in 2019 as senior vice president and general manager for the company’s Chronic Care franchise. His background includes more than 25 years as a healthcare industry executive focused on sales, marketing, strategy and general management. Prior to joining Avanos, Kerr served as Chief Commercial Officer at AlloSource, a global biologic and regenerative implant company.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on AVNS:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles